World's Best Scientists 2026 revealed!
Julia Margaret Wendy Gee

Julia Margaret Wendy Gee

D-Index & Metrics

Biology and Biochemistry

D-Index
72
Citations
19068
World Ranking
6288
National Ranking
481

Julia Margaret Wendy Gee publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Julia Margaret Wendy Gee sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 238 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Julia Margaret Wendy Gee D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Julia Margaret Wendy Gee sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 72 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Julia Margaret Wendy Gee is affiliated with Cardiff University in the United Kingdom. Their research spans several fields of biochemistry, genetics, molecular biology, and medicine, with a focus on molecular biology, oncology, genetics, cancer research, and biomedical engineering.

Their work addresses key topics including epigenetics and DNA methylation, estrogen and related hormone effects, histone deacetylase inhibitors research, genomics and chromatin dynamics, cancer cells and metastasis, trace elements in health, and RNA research and splicing.

Significant recent publications by Julia Margaret Wendy Gee include:

  • Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer, 2020, Nature Communications
  • The ZIP6/ZIP10 heteromer is essential for the zinc-mediated trigger of mitosis, 2020, Cellular and Molecular Life Sciences
  • The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer, 2024, Nature Structural & Molecular Biology
  • Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer, 2022, npj Breast Cancer
  • 4th generation nonsteroidal aromatase inhibitors: An iterative SAR-guided design, synthesis, and biological evaluation towards picomolar dual binding inhibitors, 2022, European Journal of Medicinal Chemistry

Their collaborations include frequent co-authorship with Joanna Achinger-Kawecka, C. Elizabeth Caldon, Shalima S. Nair, Qian Du, and Clare Stirzaker, each contributing jointly on multiple publications.

Julia Margaret Wendy Gee's research has been published in several venues, with repeated contributions to the Journal of the American Association for Laboratory Animal Science and bioRxiv (Cold Spring Harbor Laboratory). Other publications have appeared in Nature Communications, Cellular and Molecular Life Sciences, and Nature Structural & Molecular Biology.

Best Publications

  • EGFR and cancer prognosis

    Robert Ian Nicholson;Julia Margaret Wendy Gee;Maureen Elaine Harper

  • Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells

    Janice Mary Knowlden;Iain Robert Hutcheson;Helen E. Jones;Tracie-Ann Madden

  • Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor Inhibition

    Joan Albanell;Federico Rojo;Steve Averbuch;Andrea Feyereislova

  • Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

    Suzanne A. Eccles;Eric O. Aboagye;Simak Ali;Annie S. Anderson

  • Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

    Jennifer H. Law;Golareh Habibi;Kaiji Hu;Hamid Masoudi

  • Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor–Positive Phenotype

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;E. Claire Paish

  • Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells

    Helen E. Jones;Lindy Goddard;Julia Margaret Wendy Gee;Stephen Edward Hiscox

  • Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer

    Julia Margaret Wendy Gee;J. F. Robertson;E. Gutteridge;I. O. Ellis

  • Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).

    Richard Andrew McClelland;Denise Barrow;Tracie-Ann Madden;Carol Mary Dutkowski

  • Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer.

    Julia M.W. Gee;John F.R. Robertson;Ian O. Ellis;Robert I. Nicholson

  • Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.

    John F. Robertson;Robert I. Nicholson;Nigel J. Bundred;Elizabeth Anderson

  • Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.

    Stephen Edward Hiscox;Liam David Morgan;Tim P. Green;Denise Barrow

  • Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

    Julia M. W. Gee;Ian O. Ellis;John F. R. Robertson;Peter Willsher

  • Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

    Emad A. Rakha;Maysa E. El-Sayed;Desmond G. Powe;Andrew R. Green

  • Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.

    Frances S. Kenny;Rina Hui;Elizabeth A. Musgrove;Julia M.W. Gee

  • Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy

    Robert Ian Nicholson;Richard Andrew McClelland;Julia Margaret Wendy Gee;David L. Manning

  • Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: A supporting role to the epidermal growth factor receptor

    Janice Mary Knowlden;Iain Robert Hutcheson;Denise Barrow;Julia Margaret Wendy Gee

  • Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.

    Hany Onsy Habashy;Hany Onsy Habashy;Desmond G. Powe;Cindy M. Staka;Emad A. Rakha

  • The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro.

    J. M. W. Gee;M. E. Harper;I. R. Hutcheson;T. A. Madden

  • Immunohistochemical determination of estrogen receptor-alpha phosphorylation in activation function AF1 in primary and tamoxifen-resistant breast cancer is indicative of a complex role for estrogen receptor-alpha phosphorylation in breast cancer progression [Abstract]

    S. Ali;N. Sarwar;J. Jiang;D. Peston

Frequent Co-Authors

Robert Ian Nicholson
Robert Ian Nicholson Cardiff University
Ian O. Ellis
Ian O. Ellis University of Nottingham
John F.R. Robertson
John F.R. Robertson University of Nottingham
Susan J. Clark
Susan J. Clark Garvan Institute of Medical Research
Elizabeth A. Musgrove
Elizabeth A. Musgrove University of Glasgow
Roger W. Blamey
Roger W. Blamey Nottingham City Hospital
Andrew R. Green
Andrew R. Green University of Nottingham
Robert Clarke
Robert Clarke University of Oxford
Emad A. Rakha
Emad A. Rakha University of Nottingham
Sarah E Pinder
Sarah E Pinder King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the fields of Biology and Biochemistry opens up diverse career options in healthcare and life sciences. For those seeking a practical, skills-based pathway, consider specialized programs like ultrasound tech school which can prepare you for diagnostic imaging roles in hospitals and clinics.

Many students also look for affordable education without compromising quality. If cost is a concern, investigate the cheapest radiology tech programs that offer online coursework, leading to excellent job prospects in medical imaging.

For those interested in health and nutrition, pursuing one of the top dietetics masters programs can pave the way for a career as a registered dietitian. With the rise of telehealth, online coursework makes advanced study more accessible than ever before.

If you’re looking for entry-level roles in healthcare, accredited online medical assistant programs that accept financial aid can make training both flexible and affordable.

Whichever pathway you choose, a background in Biology or Biochemistry can provide a strong foundation for diverse and rewarding careers in the health sciences.

Best Scientists Citing Julia Margaret Wendy Gee

Trending Scientists

Recently Published Articles